Factors influencing nerve regeneration in a trial of timcodar dimesylate.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 16434669.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors assessed the ability of the neurophilin compound, timcodar dimesylate, to accelerate the return of epidermal nerve fiber density (ENFD) after a standardized nerve injury in a randomized double blind, placebo controlled trial. While there was no difference in the regeneration rate between the treatment and placebo arms, the baseline ENFD (p = 0.006), height (p = 0.02), and race (p = 0.03) were associated with the regeneration rate.
Medical subject headings
- Epidermis
- Nerve Regeneration
- Peripheral Nerve Injuries
- Pyridines